Source:http://linkedlifedata.com/resource/pubmed/id/15300407
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2004-10-13
|
pubmed:abstractText |
Antiphospholipid syndrome (APS) is an autoimmune condition characterized by thrombosis and/or recurrent fetal loss as well as the presence of autoantibodies against epitopes present on phospholipid-binding proteins. The role of cellular immunity in the pathogenesis of the syndrome remains unclear. We studied the cellular phenotype and the production of type 1 [interferon (IFN)-gamma, interleukin (IL)-2] and type 2 (IL-4, IL-10) cytokines by CD4+ and CD8+ T-lymphocyte subsets in 13 patients with untreated primary APS (PAPS) and in 32 healthy controls. The production of cytokines was determined in T cells after a 5-h culture with or without mitogenic stimulation using a flow cytometric method of intracellular cytokine staining. In six of the patients these studies were repeated 6 months later. In PAPS patients we found a reduced percentage of circulating CD4+CD45RA+ and an increased percentage and absolute number of CD8+HLA-DR+ cells. A type 1 response was observed in the patients' unstimulated cells, indicated by an increase in IFN-gamma-producing CD8+, IL-2-producing CD4+ T cells, and a decrease in IL-4-producing CD4+ and CD8+ T cells. Similar results were obtained in the patients at follow-up. Taken together, these results suggest a chronic in vivo stimulation of CD4+ and CD8+ T cells in PAPS patients exhibiting a type 1 polarization. Changes of cellular immunity may contribute to the pathogenesis of the clinical manifestations of the syndrome and might be proven to be useful targets for therapeutic interventions in the future.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0939-5555
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
704-11
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15300407-Adult,
pubmed-meshheading:15300407-Aged,
pubmed-meshheading:15300407-Antiphospholipid Syndrome,
pubmed-meshheading:15300407-CD4-Positive T-Lymphocytes,
pubmed-meshheading:15300407-CD8-Positive T-Lymphocytes,
pubmed-meshheading:15300407-Cells, Cultured,
pubmed-meshheading:15300407-Cytokines,
pubmed-meshheading:15300407-Female,
pubmed-meshheading:15300407-Humans,
pubmed-meshheading:15300407-Interferon-gamma,
pubmed-meshheading:15300407-Interleukin-10,
pubmed-meshheading:15300407-Interleukin-2,
pubmed-meshheading:15300407-Interleukin-4,
pubmed-meshheading:15300407-Male,
pubmed-meshheading:15300407-Middle Aged,
pubmed-meshheading:15300407-T-Lymphocyte Subsets,
pubmed-meshheading:15300407-Th1 Cells,
pubmed-meshheading:15300407-Th2 Cells
|
pubmed:year |
2004
|
pubmed:articleTitle |
Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome.
|
pubmed:affiliation |
Laboratory Hematology and Transfusion Medicine, School of Medicine, University of Patras, 26110, Patras, Greece. makara@med.upatras.gr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|